Arrowstreet Capital
CCXI

Arrowstreet Capital’s ChemoCentryx, Inc. CCXI Stock Holding History

Arrowstreet Capital’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-106,862
Closed -$5.52M – 1525
2022
Q3 		$5.52M Buy
+106,862
New +$4.42M 0.01% 639
2019
Q3 		– Sell
-24,700
Closed -$230K – 1773
2019
Q2 		$230K Sell
24,700
-300,048
-92% -$3.47M ﹤0.01% 1293
2019
Q1 		$4.51M Buy
324,748
+104,744
+48% +$1.2M 0.01% 826
2018
Q4 		$2.4M Buy
220,004
+9,242
+4% +$97.5K 0.01% 737
2018
Q3 		$2.66M Buy
210,762
+115,268
+121% +$1.39M 0.01% 644
2018
Q2 		$1.26M Buy
95,494
+61,278
+179% +$733K ﹤0.01% 761
2018
Q1 		$465K Buy
34,216
+8,200
+32% +$84.6K ﹤0.01% 962
2017
Q4 		$155K Buy
26,016
+8,017
+45% +$55K ﹤0.01% 1192
2017
Q3 		$134K Buy
+17,999
New +$150K ﹤0.01% 1068

Other funds holding CCXI

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Arrowstreet Capital's CCXI Position: Q4 2022 in Review

Arrowstreet Capital sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 106,862 shares — an estimated $5.52M sold.

Arrowstreet Capital first reported a position in CCXI in Q3 2017 and held it in 9 quarters. The position peaked at $5.52M in Q3 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Arrowstreet Capital reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 106,862 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5.52M.
  • Arrowstreet Capital first reported a position in ChemoCentryx, Inc. in Q3 2017 and held it in 9 quarters.
  • Arrowstreet Capital's ChemoCentryx, Inc. position peaked at $5.52M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Arrowstreet Capital's 13F filing for Q4 2022, filed 14 Feb 2023.